Item 2. Properties
Item 2. Properties
Our primary operations are conducted at the leased facilities summarized in the below table. In 2023, we completed the construction of our gene therapy manufacturing facility located in Bedford, Massachusetts. We believe our facilities are adequate and suitable for our current needs and that we will be able to obtain new or additional leased space in the future when necessary.
Property Location
Use
Lease Expiration Date
Novato, California
Headquarters and office
December 2024
Novato, California
Laboratory and office
October 2028
Brisbane, California
Office
June 2026
Somerville, Massachusetts
Laboratory and office
October 2029
Woburn, Massachusetts
Laboratory and office
April 2025
Woburn, Massachusetts
Laboratory and office
October 2026
Bedford, Massachusetts
Manufacturing facility
Owned property
66
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.